EVIMED 60

EVIMED 60

Raloxifene HCL 60mg

Form
Oral
CAS number
82640-04-8
Molecular Weight
510.00 g/mol
Formula
C28H28ClNO4S
Composition
  • Raloxifene HCL 60mg
  • Excipients q.s

Overview

EVIMED 60 (Raloxifene HCL) is a drug used by women to prevent and treat bone loss (osteoporosis) after menopause. It slows down bone loss and helps to keep bones strong, making them less likely to break. EVIMED 60 may also lower the chance of getting a certain type of breast cancer after menopause. EVIMED 60 is manufactured as 60mg tablets containing Raloxifene HCL 60mg and excipients.

Raloxifene Mechanism of Action

Raloxifene HCL belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. It exhibits estrogenic activity in some tissues like the bone and liver, while it shows antiestrogenic activity in the breasts and uterus. In the bone, it increases bone density and that is why it is useful in treating osteoporosis. In the breast, it opposes estrogen activity, and this action is useful in the treatment and prevention of some types of breast cancers.

Raloxifene Side Effects

Hot flashes, Leg cramps, blood clots, vaginal dryness.

Raloxifene Interactions

Estrogen, cholestyramine, tibolone, and colestipol.

Deus Medical does not sell to the public. This product reaches you through an authorised distributor. Apply to distribute it.

More in Selective Estrogen Receptor Modulator (SERM)

All 4 in Selective Estrogen Receptor Modulator (SERM)